Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 5,704,000 | 5,193,000 | 5,449,000 | 5,254,000 | 5,144,000 |
| Cost of Goods | 1,625,000 | 1,584,000 | 1,601,000 | 1,579,000 | 1,569,000 |
| Gross Profit | 4,079,000 | 3,609,000 | 3,848,000 | 3,675,000 | 3,575,000 |
| Operating Expenses | 3,562,000 | 1,830,000 | 3,150,000 | 2,492,000 | 2,280,000 |
| Operating Income | 517,000 | 1,779,000 | 698,000 | 1,183,000 | 1,295,000 |
| Pre-tax Income | 517,000 | 1,779,000 | 698,000 | 1,183,000 | 1,295,000 |
| Income Tax | 135,000 | 284,000 | 3,027,000 | 327,000 | 373,000 |
| Net Income Continuous | 382,000 | 1,495,000 | -2,329,000 | 856,000 | 922,000 |
| Minority Interests | 9,000 | 9,000 | -1,000 | 11,000 | 6,000 |
| Net Income | $373,000 | $1,486,000 | $-2,328,000 | $845,000 | $916,000 |
| EPS Basic Total Ops | 0.23 | 0.91 | -1.42 | 0.52 | 0.56 |
| EPS Basic Continuous Ops | 0.23 | 0.92 | -1.41 | 0.52 | 0.56 |
| EPS Diluted Total Ops | 0.23 | 0.91 | -1.40 | 0.51 | 0.56 |
| EPS Diluted Continuous Ops | 0.23 | 0.91 | -1.40 | 0.52 | 0.56 |
| EBITDA(a) | $674,000 | $1,922,000 | $895,000 | $1,371,000 | $1,506,000 |